Cardinal Health, Inc. (NYSE:CAH) was downgraded by stock analysts at BidaskClub from a “buy” rating to a “hold” rating in a research note issued on Monday, July 24th.
Several other analysts have also recently commented on CAH. Zacks Investment Research upgraded shares of Cardinal Health from a “strong sell” rating to a “hold” rating in a research note on Tuesday, June 20th. Needham & Company LLC began coverage on shares of Cardinal Health in a research note on Tuesday, April 4th. They issued a “hold” rating for the company. Vetr upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and set a $77.92 target price for the company in a research note on Wednesday, June 7th. Evercore ISI restated an “outperform” rating on shares of Cardinal Health in a research note on Tuesday, July 4th. Finally, Barclays PLC reiterated an “overweight” rating and issued a $82.00 price objective (down previously from $88.00) on shares of Cardinal Health in a research note on Saturday, April 22nd. Two research analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $80.46.
Cardinal Health (CAH) traded down 0.49% on Monday, reaching $66.98. 1,750,306 shares of the company were exchanged. The stock has a market capitalization of $21.17 billion, a price-to-earnings ratio of 16.62 and a beta of 0.80. The stock has a 50-day moving average price of $75.67 and a 200 day moving average price of $76.86. Cardinal Health has a 52 week low of $62.70 and a 52 week high of $84.88.
Cardinal Health (NYSE:CAH) last released its earnings results on Wednesday, August 2nd. The company reported $1.31 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.24 by $0.07. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The company had revenue of $32.97 billion during the quarter, compared to analysts’ expectations of $32.73 billion. During the same quarter last year, the business earned $1.14 EPS. The business’s revenue was up 5.0% on a year-over-year basis. Analysts forecast that Cardinal Health will post $4.97 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: This news story was originally posted by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.com-unik.info/2017/08/12/cardinal-health-inc-nysecah-lowered-to-hold-at-bidaskclub-updated-updated.html.
Institutional investors have recently made changes to their positions in the company. Alpha Windward LLC boosted its position in shares of Cardinal Health by 0.7% in the second quarter. Alpha Windward LLC now owns 2,299 shares of the company’s stock worth $179,000 after buying an additional 17 shares during the last quarter. HL Financial Services LLC boosted its position in shares of Cardinal Health by 0.3% in the first quarter. HL Financial Services LLC now owns 11,887 shares of the company’s stock worth $969,000 after buying an additional 38 shares during the last quarter. Edmond DE Rothschild Holding S.A. boosted its position in shares of Cardinal Health by 0.9% in the first quarter. Edmond DE Rothschild Holding S.A. now owns 4,321 shares of the company’s stock worth $353,000 after buying an additional 39 shares during the last quarter. Private Trust Co. NA boosted its position in shares of Cardinal Health by 0.3% in the first quarter. Private Trust Co. NA now owns 13,731 shares of the company’s stock worth $1,119,000 after buying an additional 41 shares during the last quarter. Finally, Wetherby Asset Management Inc. boosted its position in shares of Cardinal Health by 0.5% in the second quarter. Wetherby Asset Management Inc. now owns 8,392 shares of the company’s stock worth $654,000 after buying an additional 44 shares during the last quarter. Institutional investors own 87.09% of the company’s stock.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
What are top analysts saying about Cardinal Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cardinal Health Inc. and related companies.